_01_KP_7_8_2021__Undas
  • „ FROM THE EDITOR

The highest Impact Factor of Kardiologia Polska announced
in June 2021: we did it!

Anetta Undas1, 2

1Institute of Cardiology, Jagiellonian University Medical College, Kraków, Poland

2John Paul II Hospital, Kraków, Poland

Correspondence to:

Prof. Anetta Undas, MD, PhD,

Institute of Cardiology, Jagiellonian University Medical College,

Prądnicka 80,
31–202 Kraków, Poland,

phone: +48 12 614 30 04,

e-mail:
mmundas@cyf-kr.edu.pl

Copyright by the Author(s), 2021

Kardiol Pol. 2021;
79 (7–8): 723–724;
DOI: 10.33963/KP.a2021.0082

Received:
July 30, 2021

Revision accepted:
July 30, 2021

Published online:
August 25, 2021

On June 30, 2021, new Impact Factor (IF) values have been announced by Clarivate Analytics. As expected, the 2020 IF for Kardiologia Polska (Kardiol Pol, Polish Heart Journal) has exceeded not only 2.0, but also 3.0. Its exact value is 3.108. This is a recognition of the quality of the research published in our journal. The IF shows a previously underestimated potential of Polish cardiology, both the academic and non-academic settings, a growing number of cardiologists dealing with patients suffering from a wide spectrum of cardiac disorders and exploring novel pathophysiological mechanisms underlying cardiovascular diseases. I would like to thank you all our authors, reviewers, and editorial board members for your invaluable contribution to the journal’s success. The major contributors to the 2020 IF among all original and review articles published in Kardiol Pol, including 4 high-quality invited reviews from international experts, have been listed in
Table 1.

Table 1. Ten papers published in our journal in 2018 or 2019, which were most cited in 2020 and most contributed to the 2020 IF of 3.108 (derived from JCR 2021 published on June 30, 2021)

Title

Authors

Reference

Citation count

Oxidative stress and cardiovascular disease: new insights

Pignatelli P, Menichelli D, Pastori D, et al.

Volume: 76, Issue: 4, Pages: 713–722; Published: 2018

19

Hematological indices as predictors of atrial fibrillation following isolated coronary artery bypass grafting, valvular surgery, or combined procedures: a systematic review with meta-analysis

Weymann A, Ali-Hasan-Al-
-Saegh S, Popov A-F, et al.

Volume: 76, Issue: 1, Pages: 107–118, Published: 2018

13

Catheter ablation of atrial fibrillation: current status, techniques, outcomes, and challenges

Hindricks G, Shamloo AS, Lenarczyk R, et al.

Volume: 76, Issue: 12, Pages: 1680–1686; Published: 2018

13

Differences in knowledge among patients with atrial fibrillation receiving non-vitamin K antagonist oral anticoagulants and vitamin K antagonists

Konieczynska M, Sobieraj E, Bryk A, et al.

Volume: 76, Issue: 7, Pages: 1089–1096; Published: 2018

12

Safety and efficacy of ETC-1002 in hypercholesterolemic patients: a meta-analysis of randomized controlled trials

Wang X, Luo S, Gan X, et al.

Volume: 77 Issue: 2 Pages: 207–216; Published: 2019

11

How can we reverse bleeding in patients on direct oral anticoagulants?

Crowther M, Cuker A

Volume: 77, Issue: 1, Pages: 3–11;
Published: 2019

10

Fungal endocarditis: what do we know in 2019?

Ammannaya GKK, Sripad N

Volume: 77, Issue 7–8, Pages 670–673; Published: 2019

10

The usefulness of C-reactive protein for the prediction of post-infarct left ventricular systolic dysfunction and heart failure

Świątkiewicz I, Taub PR

Volume: 76, Issue 5, Pages 821–829; Published: 2018

9

Baseline and postoperative levels of C-reactive protein and interleukins as inflammatory predictors of atrial fibrillation following cardiac surgery: a systematic review and meta-analysis

Weymann A, Sedaghat M, Baker WL, et al.

Volume: 76, Issue 2, Pages 440–451; Published: 2018

9

Primary safety and effectiveness feasibility study after surgical aortic valve replacement with a new generation bioprosthesis: one-year outcomes

Bartuś K, Litwinowicz R, Kuśmierczyk M, et al.

Volume: 76, Issue 3, Pages 618–624, Published: 2018

7

The scientists who most frequently cited the articles from Kardiol Pol in 2020 have also been provided in Table 2.

Table 2. Ten top citing authors

Authors

Number of citing papers

Number of citing papers from Kardiol Pol

Number of citing papers from other journals

Undas Anetta

21

3

18

Lesiak Maciej

15

11

4

Opolski Grzegorz

12

5

7

Gąsior Mariusz

12

7

5

Podolec Piotr

11

4

7

Wojakowski Wojciech

11

7

4

Kapelak Bogusław

10

2

8

Grygier Marek

10

5

5

Kopeć Grzegorz

10

3

7

Grabowski Marcin

10

5

5

Our top reviewers from 2020 whose insightful and timely reviews are essential in our editorial efforts and will contribute to the IF to be announced in 2022 and 2023 are listed in Table 3.

Their work is greatly appreciated and deserves our recognition.

A journal’s IF, a basic measure of the quality of journals, is determined by dividing all citations to this journal within the particular year (2020 in this case) by the number of citable articles encompassing original articles and reviews published in this journal during the two precedent years (in 2018 and 2019 in this case, the years in which most articles were published based on the decision of the current Editors). Indeed, the current IF of 3.108 proves how well our team has selected and disseminated the content of Kardiol Pol. Since the latest IF markedly influences an author’s choice of where to publish their manuscripts, we hope that more and more good papers will be submitted and finally published in Kardiol Pol. To maintain our standing and ensure further growth, we promise to the cardiology community in Poland that the articles in the years to come will be as good as they possibly can be. Excellence, innovative hypotheses, and sound methodology are the keys to successful submissions to Kardiol Pol. This is the source of success. We firmly believe that we are achieving our aims beyond the current IF and our present strategy guarantees that the journal’s reputation and prestige we have increased are solid.

Our next goal is that the 2021 IF of Kardiol Pol will surpass the current value. We can achieve more, and we will do so. We hope that the joint efforts of authors, reviewers, and editors, supported by the publisher’s expertise and experience, will lead to the continued growth of our journal and the promotion of high-quality research in the field of cardiology.

Article information

undas%20tron.tif

Several opinion leaders from the Polish Cardiac Society have supported my team in our hard work to enhance the standing of Kardiologia Polska. I do appreciate stimulating remarks and trust in my ability to lead the editorial team to achieve the Impact Factor higher than 2.5 within 3 years, presented by Prof. Piotr Pruszczyk during a session sponsored by Boehringer Ingelheim at the Spring Conference of the Polish Cardiac Society in May 2018. As a proof, a funny slide from this event is presented above (with permission)

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Sp. z o.o. VM Group Sp.k., ul. Świętokrzyska 73 , 80–180 Gdańsk, Poland

phone:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl